New: our quarterly report on the S&P 500, read from 500 companies’ own filings and calls.
Read the Q3 2026 report
Saturday, Nov 21, 2026
Export PASG’s income statement to Excel — free account
Passage Bio, Inc.
PASG- EPS
- n/m
- Free cash flow
- n/m
Quarter to September 2026, against a year earlier
3.92
0.31
+8.59%
Follow PASG
Alert me
What it owns vs. what it owes End of fiscal 2025, Dec 31, 2025
Shareholders’ equity is 30.1% of the balance sheet. What is a balance sheet?
Owns
$14.5MLong-term assets
$1.5MOther short-term assets
$46.3MCash & short-term investments
Funded by
$18.8MShareholders’ equity
$43.5MOther liabilities
Debt is 0.00% of the total; shareholders’ equity 30.1%.
| Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 | Dec '20 | Dec '19 | Dec '18 | |
|---|---|---|---|---|---|---|---|---|
Cash and Short Term Investments |
46.30 | 76.76 | 114.29 | 189.61 | 315.77 | 304.82 | 158.87 | 24.86 |
Other current assets |
0.83 | 1.22 | 2.74 | 6.51 | 7.57 | 10.96 | 6.75 | 8.54 |
Total current assets |
47.76 | 78.82 | 117.96 | 197.04 | 325.07 | 317.18 | 165.78 | 33.40 |
Property, Plant, Equpment (Net) |
4.11 | 9.33 | 15.30 | 22.52 | 23.81 | 2.80 | 1.09 | 0.03 |
Long-term assets (Other) |
0.24 | 0.46 | 0.43 | 4.27 | 6.20 | 8.03 | 11.75 | 0.03 |
Total non-current assets |
14.52 | 23.60 | 32.59 | 46.51 | 30.01 | 10.82 | 12.84 | — |
Total Assets |
62.28 | 102.41 | 150.55 | 243.55 | 355.08 | 328.01 | 178.61 | 33.46 |
Accounts Payable |
1.11 | 0.74 | 1.30 | 4.07 | 9.45 | 5.27 | 0.63 | 0.21 |
Accrued Expenses |
4.65 | 6.71 | 11.67 | 11.01 | 20.05 | 15.91 | 3.05 | — |
Other current liabilities |
13.75 | 8.23 | — | 11.01 | 20.05 | 15.91 | 3.05 | 0.10 |
Total current liabilities |
23.08 | 19.36 | 16.34 | 18.35 | 29.50 | 21.18 | 3.68 | 0.31 |
Non-current Revenue (Deferred) |
— | — | — | — | 6.92 | 2.08 | 0.50 | — |
Liabilities (Preferred Stock) |
— | — | — | — | — | — | 230.61 | — |
Non-current Liabilities (Other) |
— | — | — | — | — | 0.04 | 0.08 | 2.21 |
Total non-current liabilities |
20.44 | 21.79 | 22.92 | 23.83 | 6.92 | 2.12 | 231.19 | — |
Total liabilities |
43.53 | 41.15 | 39.26 | 42.18 | 36.42 | 23.29 | 234.87 | 2.52 |
Additional Paid In Capital |
723.51 | 720.49 | 705.79 | 694.73 | 675.35 | 475.62 | 2.41 | — |
Common Stock (Net) |
— | 0.01 | 0.01 | 0.01 | 0.01 | 0.00 | 0.00 | 0.00 |
Retained Earnings |
(704.76) | (659.23) | (594.47) | (492.41) | (356.28) | (170.89) | (58.66) | (13.03) |
Common Equity (Total) |
18.76 | 61.26 | 111.28 | 201.37 | 318.66 | 304.71 | (56.25) | (12.17) |
Shareholders Equity (Total) |
18.76 | 61.26 | 111.28 | 201.37 | 318.66 | 304.71 | (56.25) | (12.17) |
Shareholders Equity and Liabilities (Total) |
62.28 | 102.41 | 150.55 | 243.55 | 355.08 | 328.01 | 178.61 | — |
Shares (Common) |
3.18 | 3.16 | 2.75 | 2.73 | 2.71 | 2.28 | 0.21 | — |
Shareholders Equity (Tangible) |
18.76 | 61.26 | 111.28 | 201.37 | 318.66 | 304.71 | (56.25) | — |
Net Debt |
(46.30) | (76.76) | (114.29) | (189.61) | (315.77) | (304.82) | (158.87) | (24.86) |
Total Debt |
— | — | — | 27.11 | — | — | — | — |
In millions of $ except per-share values · columns are period end dates · fundamentals updated Nov 12, 2026